Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Melanoma 24Neoplasm Metastasis 11Skin Neoplasms 10Neoplasms 8Kidney Neoplasms 6Carcinoma, Renal Cell 4Breast Neoplasms 4Uveal Melanoma 3Lymphoma, Non-Hodgkin 3Uterine Cervical Neoplasms 2Rectal Neoplasms 2Neuroblastoma 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Leukemia, Lymphocytic, Chronic, B-Cell 2HIV Infections 2Gastrointestinal Neoplasms 2Eye Neoplasms 2Colonic Neoplasms 2Burkitt Lymphoma 2Acquired Immunodeficiency Syndrome 2Vulvar Neoplasms 1Vulvar Diseases 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1

Interventions

Filgrastim 13Cyclophosphamide 13Etoposide 12Doxorubicin 11fludarabine phosphate 10Vincristine 10Cyclosporine 10Peripheral Blood Stem Cell Transplantation 9Radiotherapy 8Prednisone 8Vinblastine 6Tacrolimus 6Rituximab 6Methotrexate 6Gemcitabine 6Bleomycin 6tanespimycin 5Vorinostat 5Ipilimumab 5Bortezomib 5temsirolimus 4Sirolimus 4Nivolumab 4Mycophenolic Acid 4Melphalan 4Magnetic Resonance Spectroscopy 4Ifosfamide 4Dacarbazine 4Cytarabine 4CTLA-4 Antigen 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Hodgkin Disease × Interleukin-2 × Clear all
NCT00001430 2008-03-04

A Randomized Study of EPOCH II Versus EPOCH II and Immunotherapy in Lymphomas

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
49 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡